Truist Financial Sticks with Hold Rating for Amgen
Truist Financial analyst Gregory Renza has maintained his hold rating on Amgen (AMGN.US).
Renza's recommendation is based on a success rate of 57.6% and an average return of 20.1% over the past year, according to TipRanks data.
TipRanks provides analysis data from financial analysts and calculates the Average Returns and Success Rates of their recommendations.